Back to Tilray® or All Bud/Flower

Details provided are based upon best-known information made available to MedBud, please reconfirm with your pharmacy. This page was last updated:
MedBud typically only updates products when availability changes, or new information is provided. An availability status from several months ago can still be valid when a product remains in/out of stock, or has been discontinued.

Dosing Look-Up Table (Estimated)

0.01/g2.2/mg THCTrace CBD
0.05/g11/mg THCTrace CBD
0.1/g22/mg THCTrace CBD
0.15/g33/mg THCTrace CBD
0.2/g44/mg THCTrace CBD
0.25/g55/mg THCTrace CBD
0.3/g66/mg THCTrace CBD
/gCalculate THCCalculate CBD

Please note values above are based on registered THC/CBD percentages, subject to ±10% allowed variance. Values provided are 'best case', losses to air during vaporisation or combustion will always occur.

Medication Details

Brand
America Tilray®
Designation
T22
Cultivar/Strain
Galaxy Walker OG
Classification
Hybrid
Chemotype
Type I: High THC
Flower Provided
Trimmed Whole Flower
THC Potential Range (±10%)
19.8-24.2%
CBD Potential Range (±10%)
<1%
Cultivated/Produced by
Portugal Tilray Medical
Cultivated in
Flag of Portugal Portugal
Irradiation
Gamma-Irradiated
Monograph Conformity
5.1.4
Imported by
United Kingdom IPS Pharma
Imported as
Schedule II: Finished Product
Packaged in
Flag of Germany Germany

Stock Availability

We provide stock/pharmacy information only for use by medical cannabis patients, clinicians and pharmacists*.

Best-Known Status: Available

We try to ascertain stock status strictly based on the importer/distributor supplying pharmacies. Availability at individual pharmacies will differ.

*Cannabis is a controlled-substance and can only be legally dispensed upon submission of a valid prescription from a prescribing clinic, ordinarily listed.

Dispensing Patient Pharmacies

Product Description Video Reviews0 Patient Reviews

America About Tilray Inc.

Tilray® Logo

A global leader in cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis and hemp company.

Tilray is a global leader in cannabis research, cultivation, processing and distribution. We aspire to lead, legitimize and define the future of our industry by building the world’s most trusted cannabis and hemp company.

A proud pioneer, we are the first GMP-certified medical cannabis producer to supply cannabis flower and extract products to tens of thousands of patients, physicians, pharmacies, hospitals, governments and researchers on five continents.

Tilray's experience is unmatched worldwide. Our team of professionals on the ground in 7 countries serves tens of thousands of patients and consumers around the globe. Our GMP-certified cultivation and production facilities are among the most advanced in the world.

We are committed to scientific research that leads to an improved quality of life for patients in a time frame that matters. We partner with leading hospitals and universities to advance the clinical applications of cannabinoids.

Tilray takes tremendous pride in our customer service, patient outreach, and physician interaction. We recognize the importance of tracking potential adverse events as well as therapeutic benefits in order to ensure the safety of our patients.

tilray.com

  Information provided is partially -sourced and may be outdated or otherwise incorrect. Please report any inaccuracies found by email.

NHS LogoFurther National Health-Service Information on Cannabis-Based Products for Medicinal Use (CBPMs)